SINT vs. SSKN, CODX, AKLI, NMTC, FEMY, MDAI, RVP, ICU, IINN, and TTOO
Should you be buying Sintx Technologies stock or one of its competitors? The main competitors of Sintx Technologies include STRATA Skin Sciences (SSKN), Co-Diagnostics (CODX), Akili (AKLI), NeuroOne Medical Technologies (NMTC), Femasys (FEMY), Spectral AI (MDAI), Retractable Technologies (RVP), SeaStar Medical (ICU), Inspira Technologies Oxy B.H.N. (IINN), and T2 Biosystems (TTOO). These companies are all part of the "surgical & medical instruments" industry.
Sintx Technologies (NASDAQ:SINT) and STRATA Skin Sciences (NASDAQ:SSKN) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, institutional ownership, profitability, valuation, dividends, community ranking, earnings and risk.
STRATA Skin Sciences has a consensus target price of $3.80, suggesting a potential upside of 871.87%. Given STRATA Skin Sciences' higher probable upside, analysts clearly believe STRATA Skin Sciences is more favorable than Sintx Technologies.
18.4% of Sintx Technologies shares are held by institutional investors. Comparatively, 32.4% of STRATA Skin Sciences shares are held by institutional investors. 0.8% of Sintx Technologies shares are held by insiders. Comparatively, 40.4% of STRATA Skin Sciences shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Sintx Technologies has a beta of 1.39, meaning that its stock price is 39% more volatile than the S&P 500. Comparatively, STRATA Skin Sciences has a beta of 1.53, meaning that its stock price is 53% more volatile than the S&P 500.
STRATA Skin Sciences received 187 more outperform votes than Sintx Technologies when rated by MarketBeat users. Likewise, 63.90% of users gave STRATA Skin Sciences an outperform vote while only 61.02% of users gave Sintx Technologies an outperform vote.
In the previous week, Sintx Technologies had 7 more articles in the media than STRATA Skin Sciences. MarketBeat recorded 10 mentions for Sintx Technologies and 3 mentions for STRATA Skin Sciences. Sintx Technologies' average media sentiment score of 0.58 beat STRATA Skin Sciences' score of 0.57 indicating that Sintx Technologies is being referred to more favorably in the media.
STRATA Skin Sciences has a net margin of -34.92% compared to Sintx Technologies' net margin of -318.99%. STRATA Skin Sciences' return on equity of -65.76% beat Sintx Technologies' return on equity.
Sintx Technologies has higher earnings, but lower revenue than STRATA Skin Sciences. Sintx Technologies is trading at a lower price-to-earnings ratio than STRATA Skin Sciences, indicating that it is currently the more affordable of the two stocks.
Summary
STRATA Skin Sciences beats Sintx Technologies on 12 of the 16 factors compared between the two stocks.
Get Sintx Technologies News Delivered to You Automatically
Sign up to receive the latest news and ratings for SINT and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding SINT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Sintx Technologies Competitors List
Related Companies and Tools
